跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LANVIS 40 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LANVIS 40 MG COMPRIMIDOS
Approved
STANDARD
LANVIS 40 MG COMPRIMIDOS
Aspen Pharma Trading Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 10, 2021
Approval ID
e8b579bd57679ec8
Company
Aspen Pharma Trading Limited
Type
Standard
Approval Details
Approval Id
e8b579bd57679ec8
Drug Cima Aemps Name
LANVIS 40 MG COMPRIMIDOS
Register Number
84019
Holder Company Name
Aspen Pharma Trading Limited
Marketing Company Name
Aspen Pharmacare Espana S.L.
Holder Company Detail Path
/organization/aspen-pharma-trading-limited
Authorization Date
2021-03-10
Dosage Form
COMPRIMIDO
Dose
40 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Aspen Pharma Trading Limited
Company Detail Path
/organization/aspen-pharma-trading-limited
Company Information
Pharmaceutical Company Name
ASPEN PHARMA TRADING LIMITED
Country Name
Ireland
City Name
saggart,country_ie
Address
3016 Lake Drive
Active Ingredients
TIOGUANINA
40 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 10, 2021
Approval ID
e8b579bd57679ec8
Type
Standard
Back to CIMA-AEMPS Approvals